SynthesisDrugs & aging2026
Hospitalisation as an Opportunity to Optimise Quality Use of Medicines in Older Adults: A Systematic Review.
Synthesis in Drugs & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The First 24 Hours of Hospital Admission: Early Opportunity for Pharmacotherapy Optimization in Elderly Patients with Chronic Kidney Disease.Pharmacy (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospitalisation represents an opportunity to optimise medication therapy in patients at high risk of medication-related harm. Quality Use of Medicines (QUM) activities are typically incorporated into routine care, yet their impact as part of usual inpatient practice has not been comprehensively synthesised.
objectiveThe aims of this systematic review were to determine the extent to which hospitalisation serves as an opportunity for improving QUM in older adults receiving usual inpatient care, explore barriers and facilitators influencing the implementation and sustainability of QUM activities during hospitalisation, and identify which components of usual care most effectively improve medication appropriateness and safety.
methodsWe conducted a systematic review of observational studies, identified using Medline, Embase, and International Pharmaceutical Abstracts, from January 2010 to May 2025. Eligible studies included older adults (≥ 65 years) admitted to hospital for at least 24 hours, where healthcare professionals delivered QUM-related activities as part of usual care during hospitalisation. Measurable changes in medications between admission and discharge using QUM indicators were reported. Methodological quality was assessed using the Joanna Briggs Institute (JBI) cohort checklist and findings were synthesised narratively.
resultsTwenty-one studies met the inclusion criteria. Nineteen were rated as high quality and two as moderate quality. All studies evaluated changes in prescribing, most commonly using explicit tools such as the Beers criteria, Screening Tool to Alert to Right Treatment and guideline-based assessments of therapy. Ten studies showed usual care led to improvements in QUM indicators, including reduction in potentially inappropriate medicines (PIM) in settings with strong multidisciplinary involvement and structured medication reviews. However, 11 studies reported that QUM did not improve, with persistent or increased PIM use and polypharmacy at discharge. Factors contributing to ongoing QUM problems included limited clinician awareness, fragmented communication, inadequate documentation, constrained resources, poor integration of pharmacists, and variable use of QUM tools.
conclusionHospitalisation represents an important but inconsistently realised opportunity to optimise QUM in older adults. Inappropriate prescribing and polypharmacy frequently persist at discharge, indicating missed opportunities within usual care. System-level strategies embedding structured medication reviews, pharmacist involvement, explicit QUM tools, and robust documentation into routine practice may enhance medication safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.